The haemodynamic stress response to tracheal extubation is a well-described phenomenon 1 . It can have disastrous implications in patients with compromised cardiac function. We describe a novel approach in the management of tracheal extubation in a patient with poor ventricular function who failed tracheal extubation several times due to the development of acute pulmonary oedema.
The haemodynamic stress response to tracheal extubation is a well-described phenomenon 1 . It can have disastrous implications in patients with compromised cardiac function. We describe a novel approach in the management of tracheal extubation in a patient with poor ventricular function who failed tracheal extubation several times due to the development of acute pulmonary oedema.
CASE HISTORY
A 65-year-old man presented to hospital with acute shortness of breath. He had been unwell with nonproductive cough for one day without any fever or rigors. He denied chest pain, was dyspnoeic and had poor peripheral perfusion. His past medical history included diet controlled type 2 diabetes mellitus and hypertension. Physical examination showed a heart rate of 140 beats per minute, a blood pressure of 170/90 mmHg and bilateral pulmonary crackles. On arrival in the emergency department his trachea was intubated because of refractory hypoxaemia and he was transferred to our ICU for further management.
Laboratory investigation confirmed a raised troponin I level of 19 µg/l (normal range <0.01 µg/l) and a transthoracic echocardiogram on admission demonstrated severe concentric left ventricular hypertrophy, hypokinesia of the inferior and posterior ventricular walls and impaired diastolic relaxation. Systolic function was relatively normal, with an ejection fraction of 40%
A diagnosis of non-ST segment elevation infarction was made; the patient was given aspirin, and commenced on heparin and tirofiban infusions. Over the next day, once his oxygenation improved and he was haemodynamically stable, his trachea was extubated. Immediately after extubation he became hypertensive (250/114 mmHg), tachycardic (160 bpm) and rapidly developed fulminant pulmonary oedema (Figure 1) . A trial of non-invasive ventilation was unsuccessful, necessitating reintubation and ventilation.
Over the next few days we commenced ACE inhibition with captopril 6.25 mg three times a day and attempted to introduce metoprolol 12.5 mg twice daily. Unfortunately he became hypotensive after administration of these medications. A noradrenaline infusion was commenced to support his blood pressure. Cardiac catheterization was performed on the fifth day of his stay, showing severe left ventricular systolic dysfunction with high left ventricular end diastolic pressure (40 mmHg) and triple vessel disease not amenable to angioplasty or stenting. An intra-aortic balloon pump was inserted to optimize myocardial oxygenation and reverse any myocardial stunning. This was removed after 48 hours because there was no evidence of ongoing myocardial ischaemia and he was haemodynamically stable without inotropic support. He had also improved to the point where he tolerated the introduction of ACE inhibitor and a small dose of beta-blocker. A cardiothoracic surgical consult was obtained at this stage. The surgical team considered that the risks of operating whilst medical therapy was still being optimized were too great. A second trial of extubation was attempted (ICU day 7), but again, immediately after extubation, he became hypertensive, tachycardic and hypoxic, necessitating reintubation.
Because of his recurrent episodes of pulmonary oedema following extubation, a pulmonary artery flotation catheter was sited. The pulmonary capillary wedge pressure was raised at 24 mmHg, but the cardiac index was adequate at 3.0 l/min/m 2 . It was decided to commence the patient on levosimendan. After a loading dose (12 µg/kg/min for 10 min) an infusion was administered (0.05-0.1 µg/kg/min) over the next 24 hours. Improvement occurred quickly and extubation was attempted again. However within 30 minutes, he again became diaphoretic, restless, hypertensive (200/112 mmHg), tachycardic (130 beats per minute), developed pulmonary oedema and had to be reintubated.
Following this third episode of reintubation, a new extubation strategy was proposed, based on our consensus that these episodes of pulmonary oedema were related to increases in sympathetic nervous system activity during the process of awake extubation. The patient was sat upright and propofol 160 mg injected slowly. Once he was deeply sedated, he was extubated following gentle oral and tracheal suction. He was immediately commenced on non-invasive ventilation via a tight-fitting facemask using BiPAP mode (BiPAP vision®, Respironics Inc). His airway remained patent even with deep sedation and adequate tidal volumes were obtained with non-invasive ventilation. As his sedation lightened, his heart rate and blood pressure started to rise again (Figure 1) . In response, a bolus of dexmedetomidine (6 µg/kg/h over 10 min) was administered and an infusion commenced (0.4 µg/kg/min). Over the next two days he was slowly weaned from non-invasive ventilation as his level of sedation gradually lightened, this time without difficulty. He was subsequently discharged to the coronary care unit where he awaited coronary artery bypass grafting.
DISCUSSION
Tracheal extubation and tracheal intubation evoke equally strong haemodynamic stress responses 1 . Most patients will tolerate the stress without serious sequelae, but it can lead to myocardial ischaemia with acute cardiorespiratory decompensation in patients with pre-existing severe coronary artery disease. In an observational study 2 , Barham and colleagues demonstrated a temporal relationship between tracheal extubation and myocardial ischaemia in patients undergoing coronary artery bypass grafting. All their patients were well oxygenated and haemodynamically stable before extubation.
Our patient had severely compromised left ventricular function. Although he had an essentially normal ejection fraction on his admission echocardiogram, there was evidence of significant diastolic dysfunction, and subsequent ventriculography suggested much more impairment of systolic function than had been apparent initially. Due to the stress of tracheal extubation he developed marked tachycardia and hypertension leading to myocardial ischaemia and pulmonary oedema. Anxiety and increase in the work of breathing also may have contributed to the sympathetic response. On each occasion re-sedation and ventilation led to rapid resolution of pulmonary oedema and stabilization of the cardiovascular status. The development of myocardial ischaemia with diastolic dysfunction is often reflected by a rising pulmonary capillary wedge pressure 3 . The presence of diastolic dysfunction in our patient can be deduced from impaired diastolic relaxation on transthoracic echocardiogram. A high pulmonary artery wedge pressure (24 mmHg) was also seen with pulmonary artery catheterization and his left ventricular end diastolic pressure was high (40 mmHg) during cardiac catheterization.
Duane and colleagues reported the use of esmolol, a short acting beta-blocker, to aid extubation, in a patient who failed extubation repeatedly 4 . However their patient had normal ventricular function demonstrated on a transthoracic echocardiogram. We were reluctant to use esmolol in the large doses reported (1.5 mg/kg) as our patient had severe left ventricular dysfunction.
Conti and Smith 5 used propofol for sedation in post-CABG patients and randomly allocated them to tracheal extubation while awake or while still sedated. The blood pressure and heart rate increased significantly faster and a higher proportion (53% vs 7.5%) of patients required treatment for systolic hypertension following cessation of mechanical ventilation in the awake group. In the awake group 5 out of 38 patients developed significant myocardial ischaemia, with increases in heart rate or systolic blood pressure or both. No patient in the sedated group developed myocardial ischaemia. The use of propofol during cessation of mechanical ventilation and tracheal extubation seems to protect against development of myocardial ischaemia secondary to sympathetic stimulation. Based on this evidence and previous experience of one of the authors (Kulkarni), we postulated that propofol would attenuate the sympathoadrenal response during tracheal extubation and prevent development of myocardial ischaemia and acute pulmonary oedema.
Our rationale for the use of levosimendan, a calcium channel sensitizer, was that it has been shown to be useful in patients with diastolic dysfunction 6 . It prevents calcium overload during diastole, allowing improved relaxation of cardiac muscle during diastole. Levosimendan was reported to reduce pulmonary capillary wedge pressure to a greater extent than dobutamine in patients with severe chronic heart failure 6 . The infusion was stopped after 24 hours as it is currently licensed for use for 24 hours only. Levosimendan has an active metabolite (OR-1896), which has an elimination half-life of 81 hours 7 . The benefits of levosimendan have also been shown to be sustained for at least 24 hours post infusion 8 and thus should have covered the third period of tracheal extubation.
High-level non-invasive pressure support ventilation (NIPSV) has been shown to be useful in patients with severe pulmonary oedema 9 and Hoffman and colleagues were able to avoid tracheal intubation in 28 out of 29 patients 9 . In this case, we were able to use non-invasive ventilation after tracheal extubation as a bridge to successful weaning. As the patient slowly emerged from propofol sedation, he again became anxious and his pulse rate and blood pressure started rising. Dexmedetomidine, a highly selective alpha-2 adrenergic agent, has been shown to be an effective agent for ICU sedation 10 . Venn and Grounds reported that patients who received dexmedetomidine had significantly lower heart rates throughout the period of sedation and this trend persisted in the peri-extubation period 10 . By lowering the rate-pressure product, dexmedetomidine may thus lower the risk of ischaemic events. In animal studies 11 dexmedetomidine has been shown to reduce blood flow in the nonischaemic myocardium and preserve flow to the ischaemic myocardium.
The risk of aspiration of gastric contents is always a concern when extubating the tracheas of intensive care patients, and because of this, it is our routine practice to have our patients fully awake when tracheal extubation is considered. This case report illustrates the point that it may be more appropriate to individualize the tracheal extubation strategy. A change of approach using judicious sedation and sympatholysis may be useful in such circumstances.
